MADELINE TODD: Open Payments
NPI 1720773674 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,861 in 62 payments from 15 companies in 2025. Trend: 2023 $3,292 · 2024 $4,317 · 2025 $1,861
Food & beverage: $1,778Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $390 |
| UCB, Inc. | 2 | $238 |
| Regeneron Healthcare Solutions, Inc. | 9 | $215 |
| LEO Pharma Inc. | 6 | $205 |
| GENZYME CORPORATION | 8 | $193 |
| Galderma Laboratories, L.P. | 9 | $186 |
| Janssen Biotech, Inc. | 3 | $128 |
| E.R. Squibb & Sons, L.L.C. | 1 | $102 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $34 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, TREMFYA, VRAYLAR, ANZUPGO, Sotyktu, ADBRY.
Industry payments across TX — which companies pay providers there.
